Svitlana Buriak wins the 11th IBFD Frans Vanistendael Award
By GlobeNewswire Published on May 16, 2025, 18:10 IST
Amsterdam, May 16, 2025 (GLOBE NEWSWIRE) — At a ceremony this afternoon, Svitlana Buriak was announced as the winner of the award for her publication titled 'International Taxation of Global Value Networks', published by IBFD Doctoral Series.
The ongoing discussions regarding the allocation of taxing rights between countries in the digital age have primarily centered around concepts such as permanent establishments (PE) and substantive economic presence. In her book, Svitlana Buriak addresses a crucial yet often overlooked aspect: the increasing trend of 'servicification' in the global economy. Adopting a multi-disciplinary approach, the author brings into focus the role of intangibles and non-equity modes of internationalization, shedding light on the challenges associated with the division of economic rent that arises from these developments. Overall, an eminently readable and thought-provoking work.
For these reasons, the jury concluded that the publication deserved to win the award, which was personally conferred by Rosa Vanistendael, the widow of Frans Vanistendael.
About the author
Dr. Svitlana Buriak is a tax advisor specializing in transfer pricing at Loyens & Loeff (Amsterdam), assistant professor at the University of Amsterdam (UvA), and director of the UvA Centre for Transfer Pricing and Income Allocation. With around 10 years of experience combining practice and policy-oriented academic work, Dr. Buriak focuses on addressing complex international tax and transfer pricing challenges through innovative and practical solutions. Her approach is grounded in legal research, economics, and policy considerations, taking into account evolving economic and business realities, as well as international relations, aiming to deliver legal analyses that are both legally sound and relevant in today's global landscape.
Applications and Nominations are welcome for the 12th IBFD Frans Vanistendael Award 2026
Submissions are accepted until 31 December 2025 at [email protected] . Competition rules for 2026 will be available on the website as of next week. The 12th Frans Vanistendael Award will be conferred at IBFD's headquarters in Amsterdam in May 2026.
About IBFD
IBFD is a leading international provider of cross-border tax expertise, with a long-standing history of supporting and contributing to tax research and academic activities. As an independent foundation, IBFD utilizes its global network of tax experts and its Knowledge Centre to serve Fortune 500 companies, governments, international consultancy firms and tax advisers.
Attachment Svitlana Buriak wins the 11th IBFD Frans Vanistendael Award
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
3 hours ago
- Business Upturn
OGN FRAUD ALERT: Organon & Co. Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 22 Legal Deadline (NYSE:OGN)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting Investors have until July 22, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Organon securities. The case is pending in the U.S. District Court for the District of New Jersey and is captioned: Hauser v. Organon & Co., et al. , No. 25-cv-05322. Why was Organon Sued for Securities Fraud? Organon is a global healthcare company focused on women's health that has historically rewarded its shareholders with a healthy dividend. In October 2024, Organon completed a $1.2 billion acquisition of Dermavant, a biopharmaceutical company focused on dermatological conditions. As alleged, while the acquisition increased Organon's debt, the Company assured investors it would maintain its dividend, which Organon asserted was its '#1 capital allocation priority.' In truth, Organon had shifted its capital allocation priority after the Dermavant acquisition to focus on reducing its debt, ultimately leading the Company to severely cut its dividend. The Stock Declines as the Truth is Revealed On May 1, 2025, Organon announced that management reset the Company's dividend payout from $0.28 per share to $0.02 per share. Organon's CEO explained that the Company 'reset our capital allocation priorities to accelerate progress towards deleveraging' and that '[b]y deleveraging more rapidly, we will continue to strengthen the future prospects of the company.' Organon's CFO added, '[t]he biggest issues we face . . . relate to managing our leverage and relate to growth. And we need capital to solve both of those issues, and so returning capital to shareholders is right now, less of a priority.' On this news, the price of Organon stock declined roughly 27%, from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025. Click here if you suffered losses: What Can You Do? If you invested in Organon you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Business Upturn
3 hours ago
- Business Upturn
IOVA FRAUD ALERT: Iovance Biotherapeutics Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 14 Legal Deadline (NASDAQ:IOVA)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting Investors have until July 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Iovance securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Sundaram v. Iovance Biotherapeutics, Inc., et al. , No. 25-cv-04177. Why was Iovance Sued for Securities Fraud? Iovance is a commercial-stage biopharmaceutical company focused on the development of treatments for melanoma and other solid tumor cancers. The Company commercially launched its key melanoma treatment Amtagvi in February 2024. Iovance administers Amtagvi at the Company's authorized treatment centers ('ATCs'). As alleged, Iovance repeatedly touted its ATCs as a driver of demand for Amtagvi. In truth, Iovance's ATCs were experiencing long timelines to begin treating patients with Amtagvi, and ineffective patient identification and patient selection for treatment was causing high patient drop-offs at the ATCs. The Stock Declines as the Truth is Revealed On May 8, 2025, Iovance reported disappointing financial results for 1Q25 and announced it was 'revising full-year 2025 revenue guidance.' The Company blamed 'recent launch dynamics,' including slow 'treatment timelines for new ATCs' and 'the variable pace at which ATCs began treating patients,' which 'differs from center to center.' Iovance also blamed the poor results on high 'patient drop-off' due to inadequate 'patient selection' for treatment. On this news, the price of Iovance stock declined more than 44%, from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025. Click here if you suffered losses: What Can You Do? If you invested in Iovance you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Business Upturn
3 hours ago
- Business Upturn
AIXA Miner Integrates AI and Clean Energy to Power a New Era of Cloud Mining in 2025
Denver, CO, USA, June 22, 2025 (GLOBE NEWSWIRE) — In a major advancement for the global crypto mining industry, AIXA Miner today announced the expansion of its AI-powered cloud mining platform, now fully supported by green energy sources. The move strengthens AIXA Miner's position as a forward-thinking player in the digital asset space, while making daily crypto income more accessible and more sustainable for users worldwide. As interest in decentralized finance grows and regulatory focus sharpens, 2025 is proving to be a pivotal year for crypto mining. AIXA Miner's cloud-based system offers a hardware-free, AI-optimized, and environmentally conscious mining solution that requires no prior technical knowledge or large capital investment. Bridging Crypto, AI, and Sustainability Designed for beginners and experienced users alike, AIXA Miner enables anyone to start earning daily rewards in leading cryptocurrencies — including Bitcoin, Ethereum, and Litecoin — through its intelligent, cloud-hosted mining architecture. The platform's unique value lies in its combination of: Artificial intelligence , used to dynamically allocate mining resources for optimal output , used to dynamically allocate mining resources for optimal output Clean energy-powered mining farms , cutting environmental impact , cutting environmental impact Free sign-up mining trial , giving newcomers a risk-free entry point , giving newcomers a risk-free entry point Low-cost mining contracts , with flexible durations and terms , with flexible durations and terms Daily payouts and full earnings control, accessible via a secure user dashboard In line with the industry's green transition, AIXA's energy-efficient infrastructure operates in regions with abundant renewable energy sources, aligning with broader ESG standards and carbon neutrality goals. Making Daily Crypto Income Simple AIXA Miner's goal is to eliminate complexity from crypto mining. Users simply register with an email, choose a mining plan (or start with the free trial), and the platform's backend takes care of everything — from resource allocation to performance tracking. With 24/7 cloud uptime, earnings accumulate automatically, and users can withdraw or reinvest anytime. This 'plug-and-earn' experience reflects a growing demand for low-risk, passive income solutions that don't rely on expensive hardware or volatile trading environments. Start Mining in Minutes Go to Register with your email to activate your free trial Choose the crypto you want to mine Let the AI-powered engine begin mining Monitor your earnings in real-time Withdraw anytime, or grow your income with longer-term plans Building a Smarter Mining Future AIXA Miner's 2025 expansion is not just about mining more coins — it's about doing so responsibly, intelligently, and inclusively. With built-in support for multiple global languages and secure wallet integrations, the platform is tailored for a worldwide user base seeking transparent, stable, and eco-friendly mining solutions. About AIXA Miner Founded in 2020, AIXA Miner is a U.S.-based cloud mining platform powered by renewable energy and artificial intelligence. With a presence in over 200 countries and regulatory certifications, the platform delivers secure, daily-yield mining services that are easy to access and designed for long-term sustainability. For more information, visit: [ Disclaimer: The information provided in this press release does not constitute an investment solicitation, nor does it constitute investment advice, financial advice, or trading recommendations. Cryptocurrency mining and staking involve risks and the possibility of losing funds. It is strongly recommended that you perform due diligence before investing or trading in cryptocurrencies and securities, including consulting a professional financial advisor. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
